PMID: 9649090Jul 2, 1998Paper

Preterm contractions in community settings: II. Predicting preterm birth in women with preterm contractions

Obstetrics and Gynecology
W J Hueston

Abstract

To examine risk factors for preterm delivery in women who present to nontertiary care hospitals with preterm contractions. Women who presented to a network of community hospitals in Wisconsin with preterm contractions were followed until delivery. The main outcomes were preterm delivery before completion of 36 weeks of gestation and delivery within 1 week of initial presentation. Of the 266 women presenting with contractions over the 2-year study period, 90% (n=239) consented to participate. Multiple factors were associated with premature delivery, but when examined with a multivariate model, only four (ruptured membranes, multiple gestation, cervical effacement at least 80%, and nonwhite race) were associated with prematurity, whereas five (ruptured membranes, multiple gestation, cervical effacement at least 80%, dilation exceeding 1 cm, and being a nonsmoker) predicted delivery within 1 week. A decision model that combined the presence of ruptured membranes and effacement at least 80% could predict delivery at 34 weeks or less within 7 days of presentation with a sensitivity of 71% and a specificity of 98%. Only two clinical cues (ruptured membranes and effacement of the cervix of 80% or more) can predict premature delivery w...Continue Reading

References

Dec 10, 1992·The New England Journal of Medicine·T J Benedetti
Mar 15, 1984·The New England Journal of Medicine·C C KorenbrotR K Laros
Jul 1, 1995·American Journal of Obstetrics and Gynecology·L C LevitonR L Goldenberg
Jul 1, 1995·American Journal of Obstetrics and Gynecology·P A Crowley
Apr 1, 1993·American Journal of Obstetrics and Gynecology·K HigbyC J Pauerstein

❮ Previous
Next ❯

Citations

Feb 11, 2003·Obstetrics and Gynecology·Jay D Iams
Apr 13, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·I VerdenikB Leskosek
Feb 24, 2001·The Australian & New Zealand Journal of Obstetrics & Gynaecology·C L RobertsD A Ellwood
Jun 14, 2015·American Journal of Obstetrics and Gynecology·C Emily KleinrouwelerEwoud Schuit
Oct 18, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Sun Min KimBo Hyun Yoon
Oct 18, 2011·American Journal of Obstetrics and Gynecology·Alison G CahillAaron B Caughey
May 6, 2017·Journal of Perinatal Medicine·Merav SharvitTal Biron-Shental
Dec 23, 2003·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·M SaitoY Taketani
Apr 3, 2008·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·T SchmitzF Goffinet
Oct 2, 2020·Journal of Perinatal Medicine·Vincent DochezEmilie Marie
May 7, 2021·BMC Pregnancy and Childbirth·Tiffany Tuck Chin WongGeorge Seow Heong Yeo
Jun 24, 2021·Biological Research for Nursing·Jeung-Im Kim, Joo Yun Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.